Newlink Genetics Cor (NLNK) 10.48 $NLNK
NewLink Genetics Reports Second Quarter 2016 Financial Results
GlobeNewswire - Fri Jul 29, 7:00AM CDT
- Management to Host Conference Call Today at 8:30 a.m. ET
NLNK: 10.48 (-0.10)
Why Earnings Season Could Be Great for NewLink Genetics (NLNK)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 7:54AM CDT
NewLink Genetics (NLNK) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank.
NLNK: 10.48 (-0.10)
NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)
GlobeNewswire - Mon Jul 25, 7:05AM CDT
NewLink Genetics Corporation(NASDAQ:NLNK), announced today that Merck (NYSE:MRK), known as MSD outside the United States and Canada, has reached two key regulatory milestones for the Ebola Zaire vaccine candidate known as V920 (rVSVDG-ZEBOV-GP). The U.S Food and Drug Administration (FDA) has granted the vaccine candidate Breakthrough Therapy Designation, and the European Medicines Agency (EMA) has provided the vaccine candidate PRIME (PRIority MEdicines) status.
MRK: 58.66 (unch), NLNK: 10.48 (-0.10)
DEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 11, 11:33AM CDT
IRVINE, CA / ACCESSWIRE / July 11, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK). Investors who purchased or otherwise acquired shares between September 17, 2013 and May 9, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
72-Hour Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 10:38PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 8, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
NEWLINK 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK
GlobeNewswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (Nasdaq:NLNK). Investor losses must relate to purchases of the Company's securities between September 17, 2013 and May 9, 2016. This action is pending in the United States District Court for the Southern District of New York.
NLNK: 10.48 (-0.10)
3-Day Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 4:27PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 8, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
July 11 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against NewLink Genetics Corporation
BusinessWire - Fri Jul 08, 1:20PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". NewLink investors have until July 11, 2016 to file a lead plaintiff motion.
NLNK: 10.48 (-0.10)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of NewLink Genetics Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Fri Jul 08, 9:54AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
NLNK: 10.48 (-0.10)
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Jul 06, 7:26PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 6, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against NewLink Genetics Corporation (NLNK) and Lead Plaintiff Deadline: July 11, 2016
ACCESSWIRE - Wed Jul 06, 9:08AM CDT
NEW YORK, NY / ACCESSWIRE / July 6, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed on behalf of those who purchased shares of NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) between September 17, 2013 and May 9, 2016 inclusive (the "Class Period".
NLNK: 10.48 (-0.10)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 7:17PM CDT
Lundin Law PC announces a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NewLink Genetics Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 23, 1:21PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". NewLink investors have until July 11, 2016 to file a lead plaintiff motion.
NLNK: 10.48 (-0.10)
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 10.48 (-0.10)
NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK
PR Newswire - Fri Jun 10, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (NasdaqGM: NLNK), if they purchased the Company's securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
NLNK: 10.48 (-0.10)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NewLink Genetics Corporation of Class Action Lawsuit and Upcoming Deadline - NLNK
ACCESSWIRE - Fri Jun 10, 5:21PM CDT
NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-03545, is on behalf of a class consisting of all persons or entities who purchased NewLink securities between September 17, 2013 and May 9, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
NLNK: 10.48 (-0.10)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving NewLink Genetics Corporation and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Fri Jun 10, 9:51AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK) securities between September 17, 2013 and May 9, 2016.
NLNK: 10.48 (-0.10)
How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
PR Newswire - Thu Jun 09, 7:00AM CDT
Some of the biggest opportunities in the equities market are found in tumultuous industries such as Biotechnology. The segment continues to present a number of remarkable trades as well as potentially good investment that are waiting to be discovered. This morning ActiveWallSt.com features these four biotech stocks in its technical alerts service: Clovis Oncology Inc. (NASDAQ: CLVS), Illumina Inc. (NASDAQ: ILMN), NewLink Genetics Corp. (NASDAQ: NLNK), and Zafgen Inc. (NASDAQ: ZFGN). Learn more about these stocks and receive your complimentary trade alerts at:
ZFGN: 3.17 (+0.13), CLVS: 14.96 (+0.68), NLNK: 10.48 (-0.10), ILMN: 170.59 (+4.24)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in NewLink Genetics Corporation to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - NLNK
GlobeNewswire - Wed Jun 08, 2:22PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of NewLink Genetics Corporation (Nasdaq:NLNK) ("NewLink" or the "Company" securities during the period between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 11, 2016 to seek appointment as lead plaintiff.
NLNK: 10.48 (-0.10)
NewLink Genetics Reports Second Quarter 2016 Financial Results
GlobeNewswire - Fri Jul 29, 7:00AM CDT
- Management to Host Conference Call Today at 8:30 a.m. ET
NLNK: 10.48 (-0.10)
Why Earnings Season Could Be Great for NewLink Genetics (NLNK)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 7:54AM CDT
NewLink Genetics (NLNK) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank.
NLNK: 10.48 (-0.10)
NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)
GlobeNewswire - Mon Jul 25, 7:05AM CDT
NewLink Genetics Corporation(NASDAQ:NLNK), announced today that Merck (NYSE:MRK), known as MSD outside the United States and Canada, has reached two key regulatory milestones for the Ebola Zaire vaccine candidate known as V920 (rVSVDG-ZEBOV-GP). The U.S Food and Drug Administration (FDA) has granted the vaccine candidate Breakthrough Therapy Designation, and the European Medicines Agency (EMA) has provided the vaccine candidate PRIME (PRIority MEdicines) status.
MRK: 58.66 (unch), NLNK: 10.48 (-0.10)
DEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 11, 11:33AM CDT
IRVINE, CA / ACCESSWIRE / July 11, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK). Investors who purchased or otherwise acquired shares between September 17, 2013 and May 9, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
72-Hour Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 10:38PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 8, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(NASDAQ: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
NEWLINK 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK
GlobeNewswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (Nasdaq:NLNK). Investor losses must relate to purchases of the Company's securities between September 17, 2013 and May 9, 2016. This action is pending in the United States District Court for the Southern District of New York. NLNK: 10.48 (-0.10)
3-Day Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 4:27PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 8, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(NASDAQ: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
July 11 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against NewLink Genetics Corporation
BusinessWire - Fri Jul 08, 1:20PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"
of investors who purchased NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". NewLink investors have until July 11, 2016 to file a lead plaintiff motion. NLNK: 10.48 (-0.10)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of NewLink Genetics Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Fri Jul 08, 9:54AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
NLNK: 10.48 (-0.10)
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Jul 06, 7:26PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 6, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against NewLink Genetics Corporation (NLNK) and Lead Plaintiff Deadline: July 11, 2016
ACCESSWIRE - Wed Jul 06, 9:08AM CDT
NEW YORK, NY / ACCESSWIRE / July 6, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed on behalf of those who purchased shares of NewLink Genetics Corporation ("NewLink" or the "Company"
(NASDAQ: NLNK) between September 17, 2013 and May 9, 2016 inclusive (the "Class Period". NLNK: 10.48 (-0.10)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 7:17PM CDT
Lundin Law PC announces a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NewLink Genetics Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 23, 1:21PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased NewLink Genetics Corporation ("NewLink" or the "Company"
(NASDAQ: NLNK) securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". NewLink investors have until July 11, 2016 to file a lead plaintiff motion. NLNK: 10.48 (-0.10)
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline. NLNK: 10.48 (-0.10)
NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK
PR Newswire - Fri Jun 10, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (NasdaqGM: NLNK), if they purchased the Company's securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York. NLNK: 10.48 (-0.10)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NewLink Genetics Corporation of Class Action Lawsuit and Upcoming Deadline - NLNK
ACCESSWIRE - Fri Jun 10, 5:21PM CDT
NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company"
(NASDAQ: NLNK) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-03545, is on behalf of a class consisting of all persons or entities who purchased NewLink securities between September 17, 2013 and May 9, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". NLNK: 10.48 (-0.10)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving NewLink Genetics Corporation and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Fri Jun 10, 9:51AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK) securities between September 17, 2013 and May 9, 2016.
NLNK: 10.48 (-0.10)
How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
PR Newswire - Thu Jun 09, 7:00AM CDT
Some of the biggest opportunities in the equities market are found in tumultuous industries such as Biotechnology. The segment continues to present a number of remarkable trades as well as potentially good investment that are waiting to be discovered. This morning ActiveWallSt.com features these four biotech stocks in its technical alerts service: Clovis Oncology Inc. (NASDAQ: CLVS), Illumina Inc. (NASDAQ: ILMN), NewLink Genetics Corp. (NASDAQ: NLNK), and Zafgen Inc. (NASDAQ: ZFGN). Learn more about these stocks and receive your complimentary trade alerts at:
ZFGN: 3.17 (+0.13), CLVS: 14.96 (+0.68), NLNK: 10.48 (-0.10), ILMN: 170.59 (+4.24)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in NewLink Genetics Corporation to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - NLNK
GlobeNewswire - Wed Jun 08, 2:22PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of NewLink Genetics Corporation (Nasdaq:NLNK) ("NewLink" or the "Company"
securities during the period between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 11, 2016 to seek appointment as lead plaintiff. NLNK: 10.48 (-0.10)
